Document:

Document

Exhibit 4.2

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934

General

As of December 31, 2020, Eventbrite, Inc. (“we,” “our” or “us”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our Class A common stock, $0.00001 par value per share. The following description summarizes the most important terms of our securities as set forth in our amended and restated certificate of incorporation and amended and restated bylaws. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth herein, you should refer to our amended and restated certificate of incorporation, amended and restated bylaws and amended and restated investors’ rights agreement (“IRA”), which are included as exhibits to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, and to the Nomination Agreement (as defined below), which is included as an exhibit to our Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 20, 2020, and to the applicable provisions of Delaware law. Our authorized capital stock consists of 1,000,000,000 shares of Class A common stock, 100,000,000 shares of Class B common stock, $0.00001 par value per share, and 100,000,000 shares of undesignated preferred stock, $0.00001 par value per share.
As of February 15, 2021, there were 61 holders of record of our Class A common stock and 82 holders of record of our Class B common stock. Because many of our shares of Class A common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial owners of our Class A common stock represented by these record holders. Our board of directors is authorized, without stockholder approval except as required by the listing standards of the New York Stock Exchange (the “NYSE”), to issue additional shares of our capital stock.

Class A Common Stock and Class B Common Stock

We have authorized a class of Class A common stock and a class of Class B common stock. In connection with our initial public offering, all outstanding shares of our existing common stock and redeemable convertible preferred stock were reclassified into shares of our Class B common stock. In addition, any options to purchase shares of our capital stock outstanding prior to our initial public offering are eligible to be settled in or exercisable for shares of our Class B common stock.

Dividend Rights

            Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine.

Voting Rights

Holders of our Class A common stock are entitled to one vote for each share, and holders of our Class B common stock are entitled to ten votes per share, on all matters submitted to a vote of stockholders. The holders of our Class A common stock and Class B common stock generally vote together as a single class on all matters submitted to a vote of our stockholders, unless otherwise required by Delaware law or our amended and restated certificate of incorporation. Delaware law could require either holders of our Class A common stock or Class B common stock to vote separately as a single class in the following circumstances:

•if we were to seek to amend our amended and restated certificate of incorporation to increase or decrease the par value of a class of our capital stock, then that class would be required to vote separately to approve the proposed amendment; and
•if we were to seek to amend our amended and restated certificate of incorporation in a manner that alters or changes the powers, preferences or special rights of a class of our capital stock in a manner that affected its holders adversely, then that class would be required to vote separately to approve the proposed amendment.

We do not provide for cumulative voting for the election of directors in our amended and restated certificate of incorporation. Our amended and restated certificate of incorporation and amended and restated bylaws establish a classified board of directors that is divided into three classes with staggered three-year terms. Only the directors in one class are subject to election by a plurality of the votes cast at each annual meeting of our stockholders, with the directors in the other classes continuing for the remainder of their respective three-year terms.

Nomination Agreement

In connection with the execution of our credit agreement (the “Credit Agreement”) with FP EB Aggregator, L.P. (“FP”), as lender, and FP Credit Partners, L.P., as the administrative agent, which Credit Agreement was amended on June 15, 2020 to, among other things, appoint Wilmington Trust, National Association as administrative agent in place of FP Credit Partners, L.P., on May 19, 2020, we entered into the Nomination Agreement (“Nomination Agreement”), with FP and Francisco Partners Management, L.P. (“FP Parent”), pursuant to which, among other things, for so long as a principal amount of at least $62.5 million remains outstanding under the Credit Agreement (“Nomination Threshold”), FP shall have the right to designate a nominee for election to our board of directors as a Class III Director (“FP Designee”) at each meeting of our stockholders at which the Class III Directors are to stand for election, subject to certain provisions as described in the Nomination Agreement, including that the FP Designee be independent of FP Parent and otherwise be acceptable to us in our reasonable discretion. Pursuant to the Nomination Agreement, at any time that the Nomination Threshold is not satisfied, the FP Designee (including any successors designated pursuant to the Nomination Agreement) shall promptly offer to resign from our board of directors. In the event the Nomination Threshold is not satisfied, FP will not regain the right to designate a FP Designee. In addition, under the Nomination Agreement, for so long as the Nomination Threshold is satisfied, FP shall have the right to designate a board observer. 

FP has designated Naomi Wheeless as the FP Designee to be voted on at the 2021 annual meeting of stockholders.

No Preemptive or Similar Rights

Our common stock is not entitled to preemptive rights, redemption or sinking fund provisions. Our Class A common stock is not subject to conversion provisions.

Conversion

Each outstanding share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. In addition, each share of Class B common stock will convert automatically into one share of Class A common stock upon any transfer, whether or not for value, except for certain permitted transfers described in our amended and restated certificate of incorporation, including transfers for tax or estate planning purposes or to other Class B stockholders upon the death or incapacity of a Class B stockholder. Once converted or transferred and converted into Class A common stock, the Class B common stock will not be reissued.

All of the outstanding shares of Class B common stock will convert automatically into shares of Class A common stock on the earlier of September 24, 2028 or the date the holders of 66-2/3% of our outstanding Class B common stock elect to convert the Class B common stock to Class A common stock. Following such conversion, each share of common stock will have one vote per share and the rights of the holders of all outstanding common stock will be identical.

Right to Receive Liquidation Distributions

If we become subject to a liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our Class A common stock and Class B common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock, unless different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A common stock and by the affirmative vote of the holders of a majority of the outstanding shares of Class B common stock, each voting separately as a class.

Fully Paid and Non-Assessable

All of the outstanding shares of our Class A and Class B common stock are fully paid and non-assessable.

Preferred Stock

No shares of our preferred stock are outstanding.

Our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to 

be included in each series and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. The holders of a majority of the voting power of all of the outstanding shares of our capital stock can also increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without a separate class vote of the holders of our preferred stock, or any separate series votes of any series thereof, unless a vote of any such holders is required pursuant to the terms of any rights designated to the preferred stock. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and might adversely affect the market price of our Class A common stock and the voting and other rights of the holders of our Class A common stock and Class B common stock. We have no current plan to issue any shares of preferred stock.

Registration Rights

Certain holders of our Class B common stock are entitled to rights with respect to the registration of their shares under the Securities Act of 1933, as amended (the “Securities Act”). These registration rights are contained in our IRA. We, along with certain holders of our Class B common stock, are parties to the IRA. The registration rights set forth in the IRA will expire on September 24, 2023. We will pay the registration expenses (other than underwriting discounts and commissions) of the holders of the shares registered pursuant to the registrations described below, including the reasonable fees, not to exceed $50,000, of one counsel for the selling holders. In an underwritten offering, the underwriters have the right, subject to specified conditions, to limit the number of shares such holders may include.

Demand Registration Rights

Certain holders of our Class B common stock are entitled to certain demand registration rights contained in our IRA. We are obligated to effect only two such registrations. If we determine that it would be seriously detrimental to our stockholders to effect such a demand registration, we have the right to defer such registration, not more than once in any 12-month period, for a period of up to 120 days.

Piggyback Registration Rights

Pursuant to our IRA, if we propose to register the offer and sale of our common stock under the Securities Act, in connection with the public offering of such common stock certain holders of our Class B common stock will be entitled to certain “piggyback” registration rights allowing the holders to include their shares in such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to (a) a registration related to a company stock plan, (b) a registration related to an SEC Rule 145 transaction, (c) a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the public offering of our common stock or (d) a registration in which the 

only common stock being registered is common stock issuable upon the conversion of debt securities that are also being registered, the holders of these shares are entitled to notice of the registration and have the right, subject to certain limitations, to include their shares in the registration.

S-3 Registration Rights

Also pursuant to our IRA, certain holders of our Class B common stock may make a written request that we register the offer and sale of their shares on a registration statement on Form S-3 if we are eligible to file a registration statement on Form S-3 so long as the request covers at least that number of shares with an anticipated offering price, net of underwriting discounts and commissions, of at least $3.0 million. These stockholders may make an unlimited number of requests for registration on Form S-3; however, we will not be required to effect a registration on Form S-3 if we have effected two such registrations within the 12 month period preceding the date of the request. Additionally, if we determine that it would be seriously detrimental to our stockholders to effect such a registration during the period that is 30 days before our good faith estimate of the date of filing of our registration, and for 90 days after the effective date of our registration, we have the right to defer such registration.

Anti-Takeover Provisions

The provisions of Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws, which are summarized below, may have the effect of delaying, deferring or discouraging another person from acquiring control of our company. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms.

Delaware Law

We are governed by the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A “business combination” includes mergers, asset sales or other transactions resulting in a financial benefit to the stockholder. An “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years did own, 15% or more of the corporation’s outstanding voting stock. These provisions may have the effect of delaying, deferring or preventing a change in our control.

Amended and Restated Certificate of Incorporation and Amended and Restated Bylaw Provisions

Our amended and restated certificate of incorporation and our amended and restated bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our board of directors or management team, including the following:

•Dual Class Stock. Our amended and restated certificate of incorporation provides for a dual class common stock structure, which provides our founders, certain investors, executives and employees with significant influence over all matters requiring stockholder approval, including the election of directors and significant corporate transactions, such as a merger or other sale of our company or our assets.

•Board of Directors Vacancies. Our amended and restated certificate of incorporation and amended and restated bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors is permitted to be set only by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board of directors and promotes continuity of management.

•Classified Board. Our amended and restated certificate of incorporation and amended and restated bylaws provide that our board of directors is classified into three classes of directors. A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is more difficult and time consuming for stockholders to replace a majority of the directors on a classified board of directors.

•Stockholder Action; Special Meeting of Stockholders. Our amended and restated certificate of incorporation provides that our stockholders may not take action by written consent, but may only take action at annual or special meetings of our stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend our amended and restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our amended and restated bylaws. Our amended and restated bylaws further provide that special meetings of our stockholders may be called only by a majority of our board of directors, the Chairperson of our board of directors or our Chief Executive Officer, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors.

•Advance Notice Requirements for Stockholder Proposals and Director Nominations. Our amended and restated bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our amended and restated bylaws also specify certain requirements regarding the form and content of a 

stockholder’s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.

•No Cumulative Voting. The Delaware General Corporation Law provides that stockholders are not entitled to cumulate votes in the election of directors unless a corporation’s certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation does not provide for cumulative voting.

•Directors Removed Only for Cause. Our amended and restated certificate of incorporation provides that stockholders may remove directors only for cause.

•Amendment of Charter Provisions. Any amendment of the above provisions in our amended and restated certificate of incorporation would require approval by holders of at least 66-2/3% of the voting power of the outstanding shares of our capital stock.

•Issuance of Undesignated Preferred Stock. Our board of directors has the authority, without further action by the stockholders, to issue up to 100,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock would enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means.

•Choice of Forum. Our amended and restated bylaws provide that a state or federal court located within the State of Delaware be the exclusive forum for: (i) any derivative action or proceeding brought on our behalf; (ii) any action asserting a breach of fiduciary duty; (iii) any action asserting a claim against us arising under the Delaware General Corporation Law; (iv) any action regarding our amended and restated certificate of incorporation or our amended and restated bylaws or (v) any action asserting a claim against us that is governed by the internal affairs doctrine. The exclusive forum provision does not apply to claims under the Securities Act or the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction.

Transfer Agent and Registrar

The transfer agent and registrar for our Class A common stock and Class B common stock is American Stock Transfer & Trust Company. The transfer agent’s address is 6201 15th Avenue, Brooklyn, NY 11219.

Listing

Our Class A common stock is listed on the NYSE under the symbol “EB.”offerletter-viveksagi1do

    155 5th Street  San Francisco, CA 94103    CONFIDENTIAL INFORMATION      Vivek Sagi  13232 Country Trails Ln.  Austin, TX 78732    Re: Employment Offer Letter    Dear Vivek,    It is my pleasure to offer you a position at Eventbrite, Inc. (“Company”), coming on board to assume a  primary role in building our business.  The details of this offer are as follows:                      Location:        Austin, Texas      Position:  Chief Technology Officer      Reporting To:   Julia Hartz       Base Salary:                  $375,000/year      Sign-On Bonus:      Equity Award Value:         $375,000    $7,000,000    Start Date:        TBD     This offer is contingent upon reference checks, background checks, clearance of any conflicts of interest,  your execution of the Proprietary Information and Invention Assignment Agreement, and your eligibility  to work in the United States.  The terms of your new position with the Company are as set forth below:     1. Position.  We are very pleased to offer you the position set forth above under “Position,”  in the location set forth above under “Location,” reporting directly to the position set forth above under  “Reporting To.”     2. Start Date.  Subject to fulfillment of the conditions imposed by this letter agreement, you  will commence this new position with the Company on the above start date.     3. Proof of Right to Work.  For purposes of federal immigration law, you will be required to  provide to the Company documentary evidence of your identity and eligibility for employment in the  United States.  Such documentation must be provided to us within three (3) business days of your start  date, or your employment relationship with us may be terminated.  DocuSign Envelope ID: 3F7720F3-165E-4E66-9F59-F7D3A733FCAB 

 

   2     4. Compensation.       (a) Base Salary.  If you accept this offer, you will receive the base salary listed above, which will  be payable in semi-monthly installments on our regular paydays, as in effect from time to time, less  applicable withholdings and deductions.       (b) Benefits.  As an employee of the Company, you will be eligible for company benefits as in  effect from time to time in accordance with our policies for similarly situated employees.     (c) Sign-On Bonus. Subject to your continued employment with the Company as set forth below,  you will earn the Sign-On Bonus listed above.  In the event you remain employed by the Company  through the six month anniversary of your start date, you will earn fifty percent of the Sign-On Bonus,  which will be paid, net of all applicable withholding taxes and other deductions, on the first regular  payday following the six month anniversary of your start date (the First Installment).  In the event you  remain employed by the Company through the one year anniversary of your start date, you will earn fifty  percent of the Sign-On Bonus, which will be paid, net of all applicable withholding taxes and other  deductions, on the first regular payday following the one-year anniversary of your start date (the Second  Installment).  Notwithstanding the foregoing, in the event your employment with the Company is  terminated by the Company without Cause (as defined below) prior to the one year anniversary of your  start date and you execute a Severance Agreement similar to the one enclosed herewith, adapted for Texas  law, that becomes effective and irrevocable within sixty (60) days following such termination, then on the  first payroll date following such release becoming effective and irrevocable you will be paid any portion  of the Sign-On Bonus that remains unpaid as of such date, less required withholding taxes.    (d) Executive Bonus Plan.  You will be eligible to participate in the Company’s Executive Bonus  Plans as approved by the Company’s CEO or the Compensation Committee of the Board of Directors  each year.  The 2020 Bonus Plan provides the opportunity to earn a bonus targeted at 50% of base salary  for CEO direct reports upon achievement of certain revenue and adjusted EBIDTA metrics.  Any bonus  you earn will be paid to you, less any required withholding taxes, at the same time bonuses are paid to  executives generally, subject to your continued employment through the date of payment.     5. Equity.  In connection with the commencement of your employment, the Company will  recommend that its board of directors (or a committee thereof) grant you a number of restricted stock  units determined by dividing $2,800,000 (the “RSUs”) by the average closing market price of the  Company’s Class A common stock over the 30-calender day period ending on the last day of the month  immediately prior to the month of the grant date. If granted, the RSUs will vest according to a four-year  vesting schedule, with 25% of the RSUs vesting at approximately the end of your first year of  employment, and the remaining shares vesting ratably on a quarterly basis over the following three years,  in each case, subject to your continued employment with the Company through the applicable vesting  date.       In connection with the commencement of your employment, the Company will also recommend  that its board of directors (or a committee thereof) grant you an option to purchase that number of shares  of the Company’s Class A common stock (the “Option”) necessary for the option to have a grant date fair  value of $4,200,000, as determined in accordance with the Company’s standard accounting assumptions  (i.e., the black-scholes value). If granted, the shares underlying the Option will vest and become  exercisable according to a four-year vesting schedule, with 25% vesting and becoming exercisable at  approximately the end of your first year of employment, and the remaining shares vesting and becoming  exercisable ratably on a monthly basis, in each case, subject to your continued employment with the  DocuSign Envelope ID: 3F7720F3-165E-4E66-9F59-F7D3A733FCAB 

 

   3  Company through the applicable vesting date.      Notwithstanding the foregoing, in the event that your employment with the Company is  terminated by the Company without Cause (as defined below) prior to the six month anniversary of your  start date, then, subject to your execution of a Severance Agreement similar to the one enclosed herewith,  adapted for Texas law, that becomes effective and irrevocable within sixty (60) days following such  termination, the vesting and, if applicable, exercisability of your equity awards shall accelerate in respect  of 12.5% of the RSUs and shares underlying the Option on the date of such termination. In the event that  your employment with the Company is terminated by the Company without Cause (as defined below)  between the six and twelve month anniversaries of your start date, then, subject to your execution of a  Severance Agreement similar to the one enclosed herewith, adapted for Texas law, that becomes effective  and irrevocable within sixty (60) days following such termination, the vesting and, if applicable,  exercisability of your equity awards shall accelerate in respect of 25% of the RSUs and shares underlying  the Option on the date of such termination.      The equity compensation shall be governed by the terms and conditions of the Company’s 2018  Stock Option and Incentive Plan, as amended (“Plan”) and the Company’s Restricted Stock Unit and Stock  Options Agreements (collectively referred to herein as “RSU and Option Agreements”).  A copy of the Plan  and the form of the RSU and Option Agreements are available for your review.  The shares underlying the  RSUs and Option issued upon the settlement of the award will be subject to various rights, restrictions and  obligations, as provided in the Plan and the RSU and Option Agreements.       6. Cause Definition.  For purposes of Paragraphs 4(c) and 5 above, “Cause” shall mean (i)  your material act of misconduct in connection with the performance of your duties to the Company,  including, without limitation, misappropriation of funds or property of the Company or any of its  subsidiaries or affiliates; (ii) your commission of any felony or a misdemeanor involving moral turpitude,  deceit, dishonesty or fraud, or any conduct that would reasonably be expected to result in material injury  or reputational harm to the Company or any of its subsidiaries or affiliates if you were retained in your  position; (iii) your continued material non-performance of your duties to the Company 30 days following  written notice thereof from the Company; (iv) your breach of any material provisions of any written  agreement between you and the Company, including without limitation, the Proprietary Information and  Invention Assignment Agreement; (v) your material violation of the Company’s written employment  policies; or (vi) your failure to cooperate with a bona fide internal investigation or an investigation by  regulatory or law enforcement authorities, after being instructed by the Company to cooperate.     7. Proprietary Information and Invention Assignment Agreement.  Your acceptance of this  offer and commencement of employment with the Company is contingent upon your execution of the  Company’s “Proprietary Information and Invention Assignment Agreement,” signed copies of which  must be delivered to an officer of the Company prior to or on your start date.      8. Conflicts of Interest.  Your employment pursuant to this offer is contingent upon you  having disclosed to the Company any potential conflicts of interest between your past employment and  future duties with the Company.  By accepting this offer of employment, you are certifying that (i) you  are not aware of any impediment to loyal and conscientious employment with the Company, (ii) you have  not engaged in any conduct or entered into any agreement that would disqualify you from employment  with the Company or in any way restrict your employment with the Company, and (iii) neither your  employment with the Company nor the discharge of your employment duties will violate any agreement  that you have executed with a third party.      DocuSign Envelope ID: 3F7720F3-165E-4E66-9F59-F7D3A733FCAB 

 

   4   You agree to the best of your ability and experience that you will at all times loyally and  conscientiously perform all of the duties and obligations required of and from you in connection with  your employment with the Company, and to the reasonable satisfaction of the Company.  During the term  of your employment, you further agree that you will devote all of your business time and attention to the  business of the Company, the Company will be entitled to all of the benefits and profits arising from or  incident to all such work services and advice and you will not render commercial or professional services  of any nature to any person or organization, whether or not for compensation, without the prior written  consent of the Company’s General Counsel or her designee and the Chief Executive Officer. By way of  illustration, but not limitation, you may not (i) accept or perform work of a nature that conflicts or  competes in any way with the business, products or services of the Company, or causes you or has  potential to cause you to be disloyal; (ii) use any Company resources including, but not limited to,  computer hardware and software, telephones, facsimile machines, and copiers, for or in connection with  any non-Company work; (iii) perform any non-Company work on Company premises; or (iv) perform  any non-Company work during normal business hours.  Nothing in this letter agreement will prevent you  from accepting speaking or presentation engagements in exchange for honoraria or from serving on  boards of charitable organizations, provided such efforts are not inconsistent with the above principles.        9. At-Will Employment.  Notwithstanding any other provision of this letter agreement to the  contrary, your employment with the Company will be on an “at will” basis, meaning that either you or the  Company may terminate your employment at any time for any reason or no reason, with or without cause.   No employee or representative of the Company, other than the Chief Executive Officer has the authority  to alter the at-will nature of your employment relationship.  The Chief Executive Officer can only do so in  a written employment agreement that is signed by both the Chief Executive Officer and yourself.     We are delighted to extend you this offer until 5 pm PDT on July 3rd and look forward to working  with you. To indicate your acceptance of the Company’s offer, please sign and date this letter agreement  in the space provided below and return it to me, along with a signed and dated copy of the Proprietary  Information and Invention Assignment Agreement.      This letter, together with the Proprietary Information and Invention Assignment Agreement, sets  forth the terms of your employment with the Company and supersedes any prior representations or  agreements, whether written or oral.  This letter may not be modified or amended except by a written  agreement, signed by the Company and by you.    If you have any questions about this offer, please call me.  We look forward to a favorable reply  and to a rewarding and productive association with you.      Sincerely,              Julia Hartz, CEO          DocuSign Envelope ID: 3F7720F3-165E-4E66-9F59-F7D3A733FCAB 

 

   5  Agreed and Accepted:      ___________________________         ______________________                            Date                                  Enclosures:   Proprietary Information and Invention Assignment Agreement; Arbitration Agreement        DocuSign Envelope ID: 3F7720F3-165E-4E66-9F59-F7D3A733FCAB 2020-07-02 

 

    This page intentionally left blank  DocuSign Envelope ID: 3F7720F3-165E-4E66-9F59-F7D3A733FCAB

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]